{
    "clinical_study": {
        "@rank": "94148", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "ABT-494 orally twice daily, low dose"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "ABT-494 orally twice daily, mid-low dose"
            }, 
            {
                "arm_group_label": "Group 3", 
                "arm_group_type": "Experimental", 
                "description": "ABT-494 orally twice daily, mid-high dose"
            }, 
            {
                "arm_group_label": "Group 4", 
                "arm_group_type": "Experimental", 
                "description": "ABT-494 orally twice daily, high dose"
            }, 
            {
                "arm_group_label": "Group 5", 
                "arm_group_type": "Placebo Comparator", 
                "description": "twice daily"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a multi center, randomized, double-blind, placebo-controlled phase 2 study in\n      subjects with moderately to severely active rheumatoid arthritis on background methotrexate\n      who have failed anti-Tumor Necrosis Factor (TNF) biologic therapy."
        }, 
        "brief_title": "A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed with RA based on either the 1987-revised American College of Rheumatology\n             (ACR) classification criteria or the 2010 American College of Rheumatology/European\n             League against Rheumatism (ACR/EULAR) criteria for \u2265 3 months.\n\n          -  Subjects must have been receiving oral or parenteral MTX therapy \u2265 3 months and on a\n             stable prescription of 7.5 to 25 mg/week for at least 4 weeks prior to initiating the\n             study drug.  Subjects should also be on a stable dose of folic acid (or equivalent)\n             for at least 4 weeks prior to initiating the study drug.  Subjects should continue\n             with their stable doses of MTX and folic acid throughout the study\n\n          -  Subjects have been treated with 1 or 2 anti-TNF biologics for \u2265 3 months but continue\n             to exhibit active RA, or had to discontinue due to intolerability or toxicity.  In\n             addition, subjects may have received up to 1 non-anti-TNF biologic (e.g., abatacept,\n             rituximab, anakinra, or tocilizumab) prior to Screening.\n\n          -  Have active RA as defined by the following minimum disease activity criteria:\n\n        >= 6 swollen joints (based on 66 joint counts) at Screening and Baseline, >= 6 tender\n        joints (based on 68 joint counts) at Screening and Baseline, hs-CRP > Upper Limit of\n        Normal (ULN) OR positive for both rheumatoid factor and anti-CCP antibody.\n\n        Exclusion Criteria:\n\n          -  Prior exposure to Janus Activated Kinase (JAK) inhibitor (e.g. tofacitinib,\n             baricitinib)\n\n          -  Pregnant or breastfeeding female\n\n          -  Ongoing or active infection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960855", 
            "org_study_id": "M13-550", 
            "secondary_id": "2013-002358-57"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group 1", 
                    "Group 2", 
                    "Group 3", 
                    "Group 4"
                ], 
                "intervention_name": "ABT-494", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Group 5", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antirheumatic Agents", 
                "Methotrexate", 
                "Anti-Inflammatory Agents"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "anti-inflammatory agents", 
            "Joint Diseases", 
            "Arthritis", 
            "Musculoskeletal Disease", 
            "antirheumatic agents"
        ], 
        "lastchanged_date": "April 8, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35216"
                    }, 
                    "name": "Site Reference ID/Investigator# 119833"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119833", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hemet", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92543"
                    }, 
                    "name": "Site Reference ID/Investigator# 119835"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119835", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80910"
                    }, 
                    "name": "Site Reference ID/Investigator# 119839"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119839", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trumbull", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06611"
                    }, 
                    "name": "Site Reference ID/Investigator# 124341"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124341", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33486"
                    }, 
                    "name": "Site Reference ID/Investigator# 119824"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119824", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32804"
                    }, 
                    "name": "Site Reference ID/Investigator# 119316"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119316", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Harbor", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34684"
                    }, 
                    "name": "Site Reference ID/Investigator# 119830"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119830", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lawrenceville", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30045"
                    }, 
                    "name": "Site Reference ID/Investigator# 125855"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125855", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morton Grove", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60053"
                    }, 
                    "name": "Site Reference ID/Investigator# 119816"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119816", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67203"
                    }, 
                    "name": "Site Reference ID/Investigator# 119831"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119831", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hagerstown", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21740"
                    }, 
                    "name": "Site Reference ID/Investigator# 119827"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119827", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wheaton", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20902"
                    }, 
                    "name": "Site Reference ID/Investigator# 119815"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119815", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lansing", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48910"
                    }, 
                    "name": "Site Reference ID/Investigator# 119823"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119823", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clifton", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07012"
                    }, 
                    "name": "Site Reference ID/Investigator# 115658"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 115658", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28210"
                    }, 
                    "name": "Site Reference ID/Investigator# 119826"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119826", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duncansville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16635"
                    }, 
                    "name": "Site Reference ID/Investigator# 115678"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 115678", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29406"
                    }, 
                    "name": "Site Reference ID/Investigator# 119821"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119821", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78705"
                    }, 
                    "name": "Site Reference ID/Investigator# 119825"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119825", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }, 
                    "name": "Site Reference ID/Investigator# 119838"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119838", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77034"
                    }, 
                    "name": "Site Reference ID/Investigator# 126203"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 126203", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98122"
                    }, 
                    "name": "Site Reference ID/Investigator# 119834"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119834", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clarksburg", 
                        "country": "United States", 
                        "state": "West Virginia", 
                        "zip": "26301"
                    }, 
                    "name": "Site Reference ID/Investigator# 119828"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119828", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Broadmeadow", 
                        "country": "Australia", 
                        "zip": "2292"
                    }, 
                    "name": "Site Reference ID/Investigator# 119338"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119338", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Merewether", 
                        "country": "Australia", 
                        "zip": "2291"
                    }, 
                    "name": "Site Reference ID/Investigator# 119341"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119341", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Lambton Heights", 
                        "country": "Australia", 
                        "zip": "2305"
                    }, 
                    "name": "Site Reference ID/Investigator# 124315"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124315", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Victoria Park", 
                        "country": "Australia", 
                        "zip": "6100"
                    }, 
                    "name": "Site Reference ID/Investigator# 125775"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125775", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "zip": "M5T 2S8"
                    }, 
                    "name": "Site Reference ID/Investigator# 124316"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124316", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "zip": "M5L 3L9"
                    }, 
                    "name": "Site Reference ID/Investigator# 115281"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 115281", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Veszprem", 
                        "country": "Hungary", 
                        "zip": "8200"
                    }, 
                    "name": "Site Reference ID/Investigator# 124318"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124318", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carolina", 
                        "country": "Puerto Rico", 
                        "zip": "00985"
                    }, 
                    "name": "Site Reference ID/Investigator# 125437"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "00909-3004"
                    }, 
                    "name": "Site Reference ID/Investigator# 127016"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 127016", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Canada", 
                "Hungary", 
                "Puerto Rico"
            ]
        }, 
        "number_of_arms": "5", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 Given With Methotrexate (MTX) in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Anti-TNF Biologic Therapy", 
        "other_outcome": [
            {
                "description": "ACRn is defined as the average of the following three variables:\nThe percentage improvement in Tender joint count (TJC);\nThe percentage improvement in Swollen joint count (SJC);\nThe median percentage improvement in the following five remaining ACR core set measures:\nPatient's Assessment of Pain using Visual Analog Scale (VAS),\nPatient's Global Assessment of Disease Activity,\nPhysician's Global Assessment of Disease Activity,\nPatient's Assessment ofPhysical Function by Heath Assessment Questionnaire - Disability Index (HAQ-DI),\nHigh sensitivity CRP", 
                "measure": "ACRn", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Proportion of subjects achieving clinical remission based on Clinical Disease Activity Index (CDAI) < or equal to 2.8", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Change from Baseline in tender/swollen joint count", 
                "safety_issue": "No", 
                "time_frame": "From Week 0 through Week 12"
            }, 
            {
                "measure": "Change from Baseline in Physician's Global Assessment of Disease Activity", 
                "safety_issue": "No", 
                "time_frame": "From Week 0 through Week 12"
            }, 
            {
                "measure": "Change from Baseline in high sensitivity C-reactive protein", 
                "safety_issue": "No", 
                "time_frame": "From Week 0 through Week 12"
            }, 
            {
                "measure": "Change from Baseline in DAS28 [CRP]", 
                "safety_issue": "No", 
                "time_frame": "From Week 0 through Week 12"
            }, 
            {
                "description": "Health Assessment Questionnaire - Disability Index (HAQ-DI), Patient's Global Assessment of Disease Activity -visual analogue scale (VAS), Patient's Assessment of Pain (VAS), Functional Assessment of Chronic Illness Therapy (FACIT)- Fatigue Scale, Rheumatoid Arthritis-Work Instability Score (RA-WIS), European Quality of Life Questionnaire-5D (EuroQoL-5D)", 
                "measure": "Change from Baseline in Patient Reported Outcomes", 
                "safety_issue": "No", 
                "time_frame": "From Week 0 through Week 12"
            }, 
            {
                "measure": "ACR20 Response Rate", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 8"
            }, 
            {
                "measure": "ACR50 Response Rate", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 8"
            }, 
            {
                "measure": "ACR70 Response Rate", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 8"
            }
        ], 
        "overall_contact": {
            "email": "susan.weszt@abbvie.com", 
            "last_name": "Susan M Weszt, BS", 
            "phone": "847-938-6572"
        }, 
        "overall_contact_backup": {
            "email": "joy.johnson@abbvie.com", 
            "last_name": "Joy  M Johnson, MS", 
            "phone": "847-936-3559"
        }, 
        "overall_official": {
            "affiliation": "AbbVie", 
            "last_name": "Steven  Jungerwirth, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "American College Rheumatology (ACR)20 Response Rate", 
            "safety_issue": "No", 
            "time_frame": "Week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960855"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "ACR70 Response Rate", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Proportion of subjects achieving low disease activity (2.6 < or equal to Disease Activity Score(DAS)28 [C-reactive protein (CRP)]< 3.2)", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Proportion of subjects achieving clinical remission based on Disease Activity Score(DAS)28 [CRP] < 2.6", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "ACR50 Response Rate", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AbbVie", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}